Aggressive disease, aggressive treatment: The adult hematopoietic stem cell transplant patient in the intensive care unit

AACN Advanced Critical Care

Volumn 22, Issue 4, 2011, Pages 349-364

  Kasberg, Heather ^a,b   Brister, Lauren ^c   Barnard, Brooke ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

communication; critical care; hematopoietic stem cell transplant; patient distress

Indexed keywords

ADULT; ARTICLE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTENSIVE CARE UNIT; NEOPLASM; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ADULT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTENSIVE CARE UNITS; NEOPLASMS;

EID: 81255142606     PISSN: 15597768     EISSN: 15597776     Source Type: Journal    
DOI: 10.1097/NCI.0b013e318232c690     Document Type: Article

References (47)

1. Heinonen H, Volin L, Zevon MA, et al. Stress among allogeneic bone marrow transplantation patients. Patient Educ Couns. 2005;56:62-71. DOI: 10.1016/j.pec.2003.12.007.
2. Grant M, Ferrell B. Quality of Life Hematopoietic Cell Transplant Model. City of Hope Pain and Palliative Resource Center. Updated October 18, 2010. http://prc.coh org/pdf/BMT%20QOL%20Model.pdf. Accessed February 28, 2010.
3. Depuydt P, Kerre T, Noens L, et al. Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: A single-centre experience [published online ahead of print November 1, 2010]. Bone Marrow Transplant. DOI: 10.1038/bmt.2010.255.
4. Scales DC, Thiruchelvam D, Kiss A, Sibbald WJ, Redelmeier DA. Intensive care outcomes in bone marrow transplant recipients: A population-based cohort analysis. Crit Care Med. 2008;12:1-9. DOI: 10.1186/cc6923.
5. Sorror M., Maris M, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8): 2912-2919.
6. Lenssen P, Aker SN. Adult hematopoietic stem cell transplantation. In: Hasse JM, Blue LS, eds. Comprehensive Guide to Transplant Nutrition. Chicago, IL: American Dietetic Association; 2002:123-146.
7. Ezzone S, Schmit-Pokorny K. Blood and marrow transplantation: Indications, procedure, process. In: Blood and Marrow Stem Cell Transplantation. Sudbury, MA: Jones and Bartlett Publishers, Inc; 2007:75-107.
8. Freedman N, Hansen-Flaschen J. Intensive care for oncology patients: Short-term prognosis. In: Parsons PE, Hesketh PJ, eds. UpToDate; 2010. http://www.uptodate com/contents/search. Accessed January 14, 2011.
9. Bach PB, Schrag D, Nierman DM, et al. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood. 2001;98:3234-3240. DOI: 10.1182/ blood.V98.12.3234.
10. Naeem N, Reed MD, Creger RJ, Youngner SJ, Lazarus HM. Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: Does it really matter? Bone Marrow Transplant. 2006;37:119-133. DOI: 10.1038/ sj.bmt.1705222.
11. Naeem N, Eyzaguirre A, Kern JA, et al. Outcome of adult umbilical cord blood transplant patients admitted to a medical intensive care unit. Bone Marrow Transplant. 2006 38 733-738 DOI: 10.1038/sj.bmt.170550.
12. Peigne V, Rusinova K, Karlin, et al. Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med. 2002; 35:512-518. DOI: 10.10007/s00134-008-1320-4.
13. McArdle JR. Critical care outcomes in the hematologic transplant recipient. Clin Chest Med. 2010;30:155-167. DOI: 10.1016/j.ccm.2008.10.0020272- 5231/08$.
14. Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides; 2010. http://www.cibmtr.org/ ReferenceCenter/ SlidesReports/SummarySlides/Pages/index.aspx. Accessed January 14, 2011.
15. Altekruse SF, Kosary CL, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010. http://seer.cancer.gov/csr/1975-2007/. Accessed January 14, 2011.
16. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Acute Myeloid Leukemia Version. http://www.nccn.org/professionals/ physician-gls/f-guidelines.asp. Accessed April 11, 2011.
17. Kessinger A, Sharp JG. The whys and hows of hema - topoietic progenitor and stem cell mobilization. Bone Marrow Transplant. 2003;31:319-329.
18. Cooper B, Creger R, eds. Handbook of Blood and Marrow Transplantation. Cleveland, OH: 2010.
19. National Marrow Donor Program. Evaluating adult patients prior to hematopoietic cell transplant eligibility. http://www.marrow.org/PHYSICIAN/Tx- Indications-Timing-Referral/Evaluating-Adult-Patients-Prio/index.html. Accessed April 12, 2011.
20. Antin JH, Yolin-Raley D. Manual of Stem Cell and Bone Marrow Transplantation. Cambridge, MA: Cambridge University Press; 2009.
21. Larson RA. General principles of hematopoietic cell transplantation for acute lymphoblastic leukemia in adults. In: Negrin RS, ed. UpToDate; 2011. http://www.uptodate.com/ contents/search. Accessed January 14, 2011.
22. Chow K, Coyle N. Providing palliative care to family caregivers throughout the bone marrow transplantation trajectory. J Hosp Pal Nurs. 2011; 13:7-13. DOI: 10.1097/NJH. 0b013e3181fce813.
23. Negrin RS. Preparative regimens for hematopoietic cell transplantation. In: Chao NJ, ed. UpToDate; 2010. http://www.uptodate. com/contents/search. Accessed January 14, 2011.
24. Jacobson NB, Parekh N, Kalaycio M. The role of parenteral nutrition in acute leukemia. Curr Hematol Malignancy Rep. 2006;1:188-194.
25. Yen KT, Lee AS, Krowka MJ, et al. Pulmonary complications in bone marrow transplant: A practical approach to diagnosis and treatments. Clin Chest Med. 2004;25(1):189-201.
26. Owczuk R, Wujtewicz MA, Sawicka W. Patients with haematological malignancies requiring invasive mechanical ventilation: Differences between survivors and nonsurvivors in intensive care unit. Support Care Cancer. 2005;13:332-338. DOI: 10.1007/s00520-004-0750-y.
27. Kerstin S, Koomans HA, Hene RJ, Verdonck LF. Acute renal failure after allogeneic myeloablative stem cell transplantation: Retrospective analysis of incidence, risk factors and survival. Bone Marrow Transplant. 2007;39: 359-365. DOI: 10.1038/sj.bmt.1705599.
28. Anaissie E. Overview of infections following hemato - poietic cell transplantation. In: UpToDate; 2010. http://www uptodate.com/contents/search. Accessed January 14, 2011.
29. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34(1):17-60.
30. Afessa B, Tefferi A, Litzow MR, Peters SG. Outcomes of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med. 2002; 166(10):1364-1368.
31. Chao N. Clinical manifestations and diagnosis of acute graft-versus-host disease. In: Negrin RS, ed. UpToDate; 2010. http://www.uptodate.com/contents/ search. Accessed January 14, 2011.
32. Muscaritoli M, Grieco G, Capria S, Iori A, Fanelli P. Nutrition and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr. 2002;75:183-190.
33. Kraner RJ. Pulmonary complications after hematopoietic cell transplantation. In: King Negrin eds. UpToDate; 2011. http://www.uptodate.com/ contents/search. Accessed January 14, 2011.
34. Solh M, Arat M, Cao Q, Majhail, Weisdorf D. Late-onset noninfectious pulmonary complications in adult allogeneic hematopoietic cell transplant recipients. Transplantation. 2011;91(7): 798-803.
35. Soubani AO, Pandya CM. The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2010;3(3):143-57.
36. National Marrow Donor Program. Posttransplant complications table. http://www.marrow.org/PHYSICIAN/Patient-Care-Post-Tx /index. Accessed January 14, 2011.
37. Xuereb MC, Dunlop R. The experience of leukemia and bone marrow transplant: Searching for meaning and agency. Psychooncology. 2003;12:397-409.
38. Siston AK, List MA, Daugherty CK, et al. Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001;27:1181-1188.
39. Fife BL, Monahan PO, Abonour R, Wood LL, Stump TE. Adaptation of family caregivers during the acute phase of adult BMT. Bone Marrow Transplant. 2009;43:959-966. DOI: 10.1038/bmt.2008.405.
40. Mehta A, Cohen SR, Chan, LS. Palliative care: A need for a family systems approach. Pall Supp Care. 2009;7: 235-243. DOI: 10/1017/s1478951509000303.
41. Hendrick SS, Cobos E. Practical model for psychosocial care. J Onc Prac. 2010;6(1):34-36.
42. Borneman T, Ferrell B, Puchalski CM. Evaluation of the FICA tool for spiritual assessment. J Pain Symptom Manage. 2010;40(2):163-173.
43. Lilly CM, Sonna LA, Haley K, Massaro E. Intensive communication: Four-year follow-up from a clinical practice study. Crit Care Med. 2003;31(5, supp):S394-S399.
44. Curtis JR, White DB. Practical guidelines for evidencebased ICU family conferences. Chest. 2008;134(4): 835-843.
45. Curtis JR, Tonelli MR. Shared decision-making in the ICU: Value, challenges, and limitations. Am J Resp Crit Care Med. 2011;183(7):840-841.
46. Chung HM, Lyckholm LJ, Smith TJ. Palliative care in BMT. Bone Marrow Transplant. 2009;43:265-273. DOI: 10.1038/ bmt.2008.436.
47. Back AL, Young JP, McCown E, et al. Abandonment at the end of life from patient, caregiver, nurse, and physician perspectives: Loss of continuity and lack of closure. Arch Intern Med. 2009;169(5):474-479.